Herpes simplex glycoprotein vaccine (Chiron)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHerpes simplex glycoprotein vaccine (Chiron)

Drug Alias NameHSV-2 gB2/gD2/MF59 vaccine - ChironTwo-component gB2 and gD2 recombinant glycoproteins subunit vaccine - Chiron

ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHerpes Simplex

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesChiron Spa

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesChiron

Active IndicationsN/A

Inactive IndicationsHerpes Simplex

ATC CodeN/A